← Journal of Market Access & Health Policy
Papers in Journal of Market Access & Health Policy
Page 4 · newest first
- Rapid literature review: definition and methodologyJournal of Market Access & Health Policy · 2023
- The impact of amortization of gene therapies funding on the results and conclusions of CEMs and BIMsJournal of Market Access & Health Policy · 2023
- Transformative potential of artificial intelligence in global health policyJournal of Market Access & Health Policy · 2023
- Budget impact analysis for avatrombopag in the treatment of chronic primary immune thrombocytopenia in adult patients refractory to other treatmentsJournal of Market Access & Health Policy · 2023
- The role of stakeholder involvement in the evolving EU HTA process: Insights generated through the European Access Academy’s multi-stakeholder pre-convention questionnaireJournal of Market Access & Health Policy · 2023
- Assessing the value of delandistrogene moxeparvovec (SRP-9001) gene therapy in patients with Duchenne muscular dystrophy in the United StatesJournal of Market Access & Health Policy · 2023
- Quantitative revenue estimates and qualitative assessments of innovative fundraising sources for treating rare diseases in ColombiaJournal of Market Access & Health Policy · 2023
- Artificial intelligence and remote patient monitoring in US healthcare market: a literature reviewJournal of Market Access & Health Policy · 2023
- Implementation of equity and access in Indian healthcare: current scenario and way forwardJournal of Market Access & Health Policy · 2023
- Projecting direct medical costs and productivity benefits of improving access to advanced therapy for rheumatoid arthritis: a projection modelling studyJournal of Market Access & Health Policy · 2023
- Cost-utility and value of information analysis of tisagenlecleucel for relapsed/refractory diffuse large B-cell lymphoma in the Irish healthcare settingJournal of Market Access & Health Policy · 2023
- Health-related quality of life in health states corresponding to different stages of perianal fistula associated with Crohn’s disease: a quantitative evaluation of patients and non-patients in JapanJournal of Market Access & Health Policy · 2023
- Cost-effectiveness of infant hypoallergenic formulas to manage cow’s milk protein allergy in FranceJournal of Market Access & Health Policy · 2022
- Innovative technologies for reverse total shoulder arthroplasty in Australia: Market access challenges and implications for patients, decision-makers, and manufacturersJournal of Market Access & Health Policy · 2022
- Machine-learning prediction for hospital length of stay using a French medico-administrative databaseJournal of Market Access & Health Policy · 2022
- Proposal of International Council for Harmonization (ICH) Guideline for the Approval of BiosimilarsJournal of Market Access & Health Policy · 2022
- Impact of the COVID-19 pandemic on the conduct of clinical trials: a quantitative analysisJournal of Market Access & Health Policy · 2022
- Systematic literature review on implicit factors influencing the HTA deliberative processes in EuropeJournal of Market Access & Health Policy · 2022
- Cost comparison of adverse event management among breast and ovarian cancer patients treated with poly (ADP-ribose) polymerase inhibitors: analysis based on phase 3 clinical trialsJournal of Market Access & Health Policy · 2022
- An integrated valuation model for payer and investorJournal of Market Access & Health Policy · 2022
- Barriers in precision medicine implementation among Advanced Nonsquamous Cell Lung Cancer-patients: A Real-World Evidence ScenarioJournal of Market Access & Health Policy · 2022
- Cost-saving prediction model of transfer to palliative care for terminal cancer patients in a Japanese general hospitalJournal of Market Access & Health Policy · 2022
- Psychometric validation of a patient-reported single-item assessment of ‘Good Day Bad Day’ in a neurogenic orthostatic hypotension population treated with droxidopaJournal of Market Access & Health Policy · 2022
- Burden of illness associated with pneumococcal infections in Japan - a targeted literature reviewJournal of Market Access & Health Policy · 2021
- Modeling long-term health and economic implications of new treatment strategies for Parkinson’s disease: an individual patient simulation studyJournal of Market Access & Health Policy · 2021
- Allocating treatment resources for hepatitis C in the UK: a constrained optimization modelling approachJournal of Market Access & Health Policy · 2021
- Cost-Effectiveness Analysis of a Prescription Digital Therapeutic for the Treatment of Opioid Use DisorderJournal of Market Access & Health Policy · 2021
- Accelerating patient access to oncology medicines with multiple indications in EuropeJournal of Market Access & Health Policy · 2021
- A conceptual framework to develop a patient-reported experience measure of the quality of mental health care: a qualitative study of the PREMIUM project in FranceJournal of Market Access & Health Policy · 2021
- Impact of health technology assessment on prescribing patterns of inhaled fixed-dose combination triple therapy in chronic obstructive pulmonary diseaseJournal of Market Access & Health Policy · 2021
- Switching from one reference biological to another in stable patients for non-medical reasons: a literature search and brief reviewJournal of Market Access & Health Policy · 2021
- An updated cost-utility model for onasemnogene abeparvovec (Zolgensma®) in spinal muscular atrophy type 1 patients and comparison with evaluation by the Institute for Clinical and Effectiveness Review (ICER)Journal of Market Access & Health Policy · 2021
- Bright line or lottery? On significance and value in medical decision makingJournal of Market Access & Health Policy · 2021
- The effects of market concentration on health care price and quality in hospital markets in Ibadan, NigeriaJournal of Market Access & Health Policy · 2021
- Economic evaluation of betibeglogene autotemcel (Beti-cel) gene addition therapy in transfusion-dependent β-thalassemiaJournal of Market Access & Health Policy · 2021
- Informing decision makers seeking to improve vaccination programs: case-study SerbiaJournal of Market Access & Health Policy · 2021
- Economic evaluation of adverse events of dabrafenib plus trametinib versus nivolumab in patients with advanced BRAF-mutant cutaneous melanoma for adjuvant therapy in GermanyJournal of Market Access & Health Policy · 2020
- An algorithm to generate correlated input-parameters to be used in probabilistic sensitivity analysesJournal of Market Access & Health Policy · 2020
- The impact of patent expiry on drug prices: insights from the Dutch marketJournal of Market Access & Health Policy · 2020
- Outcomes-based reimbursement for gene therapies in practice: the experience of recently launched CAR-T cell therapies in major European countriesJournal of Market Access & Health Policy · 2020
- Use of complete clearance for assessing treatment efficacy for 5-fluorouracil interventions in actinic keratoses: how baseline lesion count can impact this outcomeJournal of Market Access & Health Policy · 2020
- Health economic evaluation of gene replacement therapies: methodological issues and recommendationsJournal of Market Access & Health Policy · 2020
- Chinese guidelines related to novel coronavirus pneumoniaJournal of Market Access & Health Policy · 2020
- Transitioning to community-based mental health service delivery: opportunities for UkraineJournal of Market Access & Health Policy · 2020
- Health-related quality of life of patients after ischaemic stroke treated in a provincial hospital in PolandJournal of Market Access & Health Policy · 2020
- Real-world cost-effectiveness of rivaroxaban and apixaban vs VKA in stroke prevention in non-valvular atrial fibrillation in the UKJournal of Market Access & Health Policy · 2020
- Gene therapy randomised clinical trials in Europe – a review paper of methodology and designJournal of Market Access & Health Policy · 2020
- Understanding the global measurement of willingness to pay in healthJournal of Market Access & Health Policy · 2020
- Organizational aspect in healthcare decision-making: a literature reviewJournal of Market Access & Health Policy · 2020
- Clinical efficacy assessment in severe vernal keratoconjunctivitis: preliminary validation of a new penalties-adjusted corneal fluorescein staining scoreJournal of Market Access & Health Policy · 2020